title: [Thrombotic microangiopathies].
authors.affiliation: Klinik für Hämatologie, Onkologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin, Klinikum Schwabing, München.
authors.forename: M
authors.initials: M
authors.lastname: Starck
authors.affiliation: Klinik für Hämatologie, Onkologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin, Klinikum Schwabing, München.
authors.forename: C-M
authors.initials: CM
authors.lastname: Wendtner
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D003298:Coombs Test; D006463:Hemolytic-Uremic Syndrome / Q000145:classification / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010951:Plasma Exchange; D011237:Predictive Value of Tests; D011379:Prognosis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000145:classification / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D000069283:Rituximab; D015996:Survival Rate; D057049:Thrombotic Microangiopathies / Q000145:classification / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; C481642:eculizumab